Cuihong Tian | Healthcare Data Analysis | Best Researcher Award

Posted on by ScienceFather

Dr. Cuihong Tian | Healthcare Data Analysis | Best Researcher Award

First Affiliated Hospital of Shantou University Medical College | China

PUBLICATION PROFILE

Scopus

Orcid

Dr. Cuihong Tian⚡🌍

INTRODUCTION 🌟

Dr. Tian Cuihong is a highly accomplished physician and researcher specializing in cardiovascular medicine. Currently, she holds a postdoctoral research position at Shantou University Medical College. With a strong foundation in clinical practice and a deep commitment to scientific exploration, Tian’s research focuses on the molecular mechanisms behind cardiovascular diseases and the role of glycosylation in atherosclerosis. She has made a significant impact in her field through both her research and clinical practice. 🌟

EARLY ACADEMIC PURSUITS 🎓

Tian’s academic journey began at Shandong Second Medical University, where she earned her Bachelor’s degree in Clinical Medicine in 2016. Following this, she pursued a Master’s degree in Internal Medicine at Xiangya Medical College, Central South University. In 2019, Tian advanced her studies with a Doctorate in Natural and Physical Sciences from Edith Cowan University in Australia. During this time, she focused on glycobiology and its critical role in human health. 🎓

PROFESSIONAL ENDEAVORS 💼

From 2019 to 2024, Tian worked as a physician at the Cardiovascular Hospital of the First Affiliated Hospital of Shantou University Medical College. Her work involved patient care, as well as contributing to cardiovascular research. Since March 2024, she has been a postdoctoral researcher at Shantou University Medical College, where she continues her exploration of the molecular underpinnings of cardiovascular diseases, particularly through the lens of glycosylation. 💼

CONTRIBUTIONS AND RESEARCH FOCUS  ON Healthcare Data Analysis🔬

Tian’s research primarily investigates the role of immunoglobulin G N-glycosylation in atherosclerosis and its correlation with cardiovascular events. She received significant funding from Guangdong’s Science and Technology Department for her research on this subject. Her studies aim to provide better diagnostic tools and therapeutic strategies for cardiovascular diseases, with an emphasis on molecular mechanisms. 🔬

IMPACT AND INFLUENCE 🌍

Dr. Tian Cuihong has had a profound impact on the scientific community. Her groundbreaking research in glycobiology and cardiovascular medicine has contributed to a deeper understanding of the molecular pathways in cardiovascular disease. Her work on the role of glycosylation in cardiovascular health has been widely recognized, influencing future research and offering novel insights for improving patient care. 🌍

ACADEMIC CITATIONS AND PUBLICATIONS 📚

Tian has authored and co-authored several impactful research articles, published in prestigious journals such as BMJ Open, EPMA Journal, and J Global Health. Some of her significant works include studies on the association between immunoglobulin G N-glycosylation and carotid atherosclerosis, and her contributions to understanding COVID-19 testing accuracy. These publications have been highly cited and continue to influence the scientific community. 📚

HONORS & AWARDS 🏅

Throughout her career, Tian Cuihong has been recognized for her exceptional contributions to science. She has received several honors and awards for her work in cardiovascular research and glycosylation studies. Her dedication to improving diagnostic methods and patient care in cardiovascular medicine has earned her recognition within both academic and clinical circles. 🏅

LEGACY AND FUTURE CONTRIBUTIONS 🔮

Looking ahead, Tian Cuihong’s contributions to cardiovascular medicine and molecular biology are set to continue shaping the future of the field. Her ongoing research holds the potential to revolutionize diagnostic practices and treatment strategies for cardiovascular diseases. As her work progresses, she will likely leave a lasting legacy in the medical community. 🔮

FINAL NOTE ✨

Tian Cuihong’s career is a remarkable blend of clinical practice and scientific research. Her groundbreaking work in understanding the molecular mechanisms of cardiovascular diseases continues to make waves in the medical world. With her continued dedication, Tian’s future contributions promise to have a lasting impact on both research and patient care. ✨

TOP NOTES PUBLICATIONS 📚

Impacts of Molecular Drivers in Aortic Dissection
  • Authors: Cuihong Tian, Yequn Chen, Xuerui Tan
  • Journal: Clinical and Translational Discovery
  • Year: 2024
Association of Triglyceride-Glucose Index with the Risk of Incident Aortic Dissection and Aneurysm: A Large-Scale Prospective Cohort Study in UK Biobank
  • Authors: Cuihong Tian, Yequn Chen, Binyi Xu, Xuerui Tan, Zhaowei Zhu
  • Journal: Cardiovascular Diabetology
  • Year: 2024
Effectiveness of a Standardized Quality Control Management Procedure for COVID-19 RT-PCR Testing: A Large-Scale Diagnostic Accuracy Study in China
  • Authors: Mengyu Liu, Cuihong Tian, Yequn Chen, Jinxiu Zhu, Yan Zheng, Jianhua Chen, Zhen Li, Feng Xu, Liang Wu, Xingyu Wang et al.
  • Journal: Diagnostic Microbiology and Infectious Disease
  • Year: 2024
Pelvic Infection Caused by Periodontitis: A Case Report
  • Authors: Cuihong Tian, Hongle Yan, Ping Tang, Jinqiu Shi, Maolian Liang, Yanyan Wan, Weiping Li, Xizhuo Sun, Chenglu Qin
  • Journal: Case Reports in Women’s Health
  • Year: 2023
Validity and Reliability of the Persian Version of the Suboptimal Health Status Questionnaire Among University Staff in Iran
  • Authors: Erfan Ayubi, Salman Khazaei, Shiva Borzouei, Ali Reza Soltanian, Samereh Ghelichkhani, Fatemeh Karbin, Yuxiang Yan, Manshu Song, Cuihong Tian, Wei Zhang et al.
  • Journal: Journal of Global Health
  • Year: 2023

 

Dieter C. Broering | Robotic Surgery | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Dieter C. Broering | Robotic Surgery | Best Researcher Award

King Fasial Specialist Hospital and Research Center Riyadh | Saudi Arabia

Publication Profile

Scopus

Prof. Dr. Dieter C. Broering 🌍🦠

🏅 Summary

Prof. Dr. Dieter C. Broering is a leading expert in organ transplantation with a focus on robotic transplant surgery. He serves as the Executive Director of the Organ Transplant Center of Excellence at King Faisal Specialist Hospital & Research Center and as a Professor of Surgery at Alfaisal University in Riyadh. With a career spanning several decades, Prof. Broering has made groundbreaking advancements, particularly in robotic transplant surgery and split liver transplantation. He has performed over 1,600 robotic procedures and contributed to more than 300 peer-reviewed publications, positioning Saudi Arabia at the global forefront of these innovations. His leadership in transplantation has improved surgical techniques and patient outcomes worldwide.

🎓 Academic Background

  • MD – Heinrich Heine University Düsseldorf, Germany (1990)
  • PD – Habilitation, University of Hamburg, Germany (2005)
  • PhD in Clinical Hepatology – Semmelweis University, Budapest, Hungary (2005)

🏥 Clinical & Academic Appointments

  • 2020 – Present: Executive Director, Organ Transplant Center of Excellence, King Faisal Specialist Hospital, Riyadh
  • 2011 – Present: Professor of Surgery, Alfaisal University
  • 2024: Visiting Professor, National and Kapodistrian University of Athens, Greece
  • 2024: Visiting Professor, University of Naples, Italy
  • 2010 – 2020: Director, Organ Transplant Center, King Faisal Specialist Hospital

💼 Management Expertise

  • Leadership: Executive Director of the Organ Transplant Center, managing a team of 700+ staff
  • Research Oversight: Head of Transplantation Research, King Faisal Specialist Hospital
  • Committee Chair: M&M, Surgical Clerkship, and Transplant Research Committees
  • Strategic Planning: Involved in shaping policies and advancing robotic surgery and liver transplant initiatives

🌍 International Collaborations

  • Established living liver donation programs in Rotterdam and Budapest
  • Developed children’s liver transplant program in Riyadh
  • Pioneered minimally invasive donor nephrectomy with Erasmus University Rotterdam

💡 Funded Research Projects

  • DFG-Project on Living Donations: €60,000 funding for psychosocial study
  • Therapy Optimization in Liver Transplant: €350,000 phase 4 clinical trial
  • Liver Preservation Techniques Study: Focused on preservation with HTK solution
  • International Liver Transplant Research Funding: €9 million for transplantation research
  • Organ Transplant Registry Support: €408,000 for enhancing transplant data infrastructure

🏆 Awards & Honors

  • Presentation Award: Association of Northwest German Surgeons (2003)
  • ILTS Travel Award: 11th Congress of the International Liver Transplantation Society (2005)
  • AST Travel Award: American Society of Transplantation Congress (2005)
  • Best Research Paper: Surgical Research Day, KFSH&RC-Riyadh (2018)
  • Second Prize: Best Research Paper, Surgical Research Day, KFSH&RC-Riyadh (2019)

🌐 Professional Memberships

  • Vice President, International Society of Liver Surgeons (ISLS)
  • Council Member, International Living Donor Liver Transplant Group (iLDLT)
  • American College of Surgeons (ACS)
  • European Society for Organ Transplantation (ESOT)
  • European Liver Transplantation Association (ELITA)

🔬 Key Research Areas

  • Living Donor Liver Transplantation
  • Robotic Transplant Surgery
  • Pediatric Liver Transplantation
  • Surgical Innovation and Technique Refinement
  • Transplant Immunology and Post-Transplant Management

📊 Publications & Citation Metrics

  • Journal Impact Factor (IF): 1,178
  • Peer-Reviewed Publications: 300+
  • Citations: 9,000+
  • H-Index: 50
  • i10-index: 138

Publication Top Notes

Decoding the Clavien-Dindo Classification: Artificial Intelligence (AI) as a Novel Tool to Grade Postoperative Complications
    • Authors: Sebastian Manuel Staubli, Harriet Louise Walker, Fuat Hakan Saner, Michael D. Spiro, D. Aristotle Raptis
    • Journal: Annals of Surgery 🏥
    • Year: 2025 🗓️
Tri-modality Therapy in Esophageal Carcinoma is at a Crossroad
    • Authors: Yogesh Kumar Vashist, Srijan Shukla, Ehab H. Abufarhaneh, Dieter Clemens Bröering, Thammineedi Subramanyeshwar Rao
    • Journal: Annals of Surgical Oncology 🦠
    • Year: 2025 🗓️
Isolated microhematuria in potential kidney donors: evaluating kidney biopsy findings with dipstick urinalysis and urine microscopy results
    • Authors: Ehab A. Hammad, Dalia Abdullah Obeid, Dieter Clemens Bröering, Nancy Jacob, Tariq Zulfiquar Ali
    • Journal: Clinical Kidney Journal 💉
    • Year: 2025 🗓️
Molecular engineering of a fluorescent probe for highly efficient detection of human serum albumin in biological fluid
    • Authors: Raja Chinnappan, Tanveer Ahmad Mir, Shanmugam Easwaramoorthi, Abdullah Mohammed Assiri, Dieter Clemens Bröering
    • Journal: Sensors International 🔬
    • Year: 2025 🗓️
Outcomes of Fully Robotic Recipient Living Donor Liver Transplant in Relation to the Open Approach
    • Authors: Dieter Clemens Bröering, Yasser Mahmoud Elsheikh, M. M. Malagò, Markus Ulrich Boehnert, D. Aristotle Raptis
    • Journal: Transplantation 💉
    • Year: 2024 🗓️
Advanced strategies for intensive care management of acute liver failure
    • Authors: Fuat Hakan Saner, Ecaterina Scarlatescu, Andrew K. Gold, D. Aristotle Raptis, Dmitri S. Bezinover
    • Journal: Bailliere’s Best Practice and Research in Clinical Gastroenterology 🏥
    • Year: 2024 🗓️
Outcomes of Adult Right Graft Living Donor Liver Transplantation Utilizing the Robotic Platform-integrated Real-time Indocyanine Green Fluorescence Cholangiography Compared to the Open Approach
    • Authors: D. Aristotle Raptis, Yogesh Kumar Vashist, Rugved V. Kulkarni, M. M. Malagò, Dieter Clemens Bröering
    • Journal: Annals of Surgery 🏥
    • Year: 2024 🗓️
Revolutionizing Organ Transplantation with Robotic Surgery
    • Authors: Dieter Clemens Bröering, D. Aristotle Raptis, M. M. Malagò, Pierre Alain Clavien
    • Journal: Annals of Surgery 🏥
    • Year: 2024 🗓️
Robotic living donor hepatectomy is associated with superior outcomes for both the donor and the recipient compared with laparoscopic or open – A single-center prospective registry study of 3448 cases
    • Authors: D. Aristotle Raptis, Yasser Mahmoud Elsheikh, Yasir Alnemary, Leen Alshibi, Sami A. Kareem
    • Journal: American Journal of Transplantation 💉
    • Year: 2024 🗓️
Transjugular Intrahepatic Portosystemic Shunt for Budd–Chiari Syndrome: A Single-Centre Experience
    • Authors: Faisal Joueidi, Amnah Alhanaee, Hamad Abdulla Alsuhaibani, Dieter Clemens Bröering, Khalid Ibrahim Bzeizi
    • Journal: Journal of Clinical Medicine 💉
    • Year: 2024 🗓️

Rituraj Upadhyay | Healthcare Data Analysis | Best Researcher Award

Posted on by ScienceFather

Dr. Rituraj Upadhyay | Healthcare Data Analysis | Best Researcher Award

The Ohio State University, United States

Author Profiles

Orcid

Google Scholar

Research Gate

Early Academic Pursuits 🎓

Dr. Rituraj Upadhyay began his academic journey with a strong foundation in medical education at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. There, he completed his Bachelor of Medicine and Surgery (MBBS) in 2014, followed by an MD in Radiation Oncology (2017). His early medical training was marked by a deep interest in radiotherapy and oncology, leading him to pursue a Diplomate of National Board (DNB) certification in Radiation Oncology. His academic endeavors during this time reflected a commitment to advancing medical knowledge and improving patient care through radiation oncology.

Professional Endeavors 🌍

Dr. Upadhyay’s professional career has been driven by a passion for advancing radiation oncology, particularly through his work in clinical and academic settings. His residency at The Ohio State University Wexner Medical Center (2021–2025) is a notable highlight in his professional journey, demonstrating his commitment to mastering the latest technologies and treatments in radiation oncology. Dr. Upadhyay’s time at renowned institutions like MD Anderson Cancer Center and Rutgers Cancer Institute of New Jersey has further solidified his standing as an emerging leader in the field. His pursuit of innovation and excellence is evident from his involvement in advanced radiation oncology fellowships and international research collaborations.

Contributions and Research Focus 🔬

Dr. Upadhyay’s research is at the forefront of radiation oncology, with a focus on improving treatment outcomes and minimizing side effects. He has contributed significantly to clinical trials and funded research, such as the “PRIMe-STAR trial” on progressive/recurrent intracranial meningiomas and the “AVATAR” system aimed at reducing anesthesia needs in pediatric radiotherapy. His research on stereotactic radiosurgery for brain metastases and radiation therapy for conditions like penile cancer and renal stereotactic ablative therapy underscores his diverse interests in cancer treatment. His studies have potential global impact, as reflected in his leadership role in multinational research endeavors.

Impact and Influence 🌟

Dr. Upadhyay’s influence extends beyond his research. As an educator and mentor, he actively shapes the next generation of radiation oncologists. His roles in mentoring medical students, residents, and fellows at institutions like The Ohio State University and Massachusetts General Hospital highlight his dedication to guiding aspiring professionals. He also plays a key role in enhancing the field through his involvement in various professional organizations such as the American Society for Radiation Oncology (ASTRO) and the Radiosurgery Society (RSS). His work as a guideline reviewer and committee member for several radiation oncology societies reflects his broad influence on the development of standards and best practices in the field.

Academic Cites 📚

Dr. Upadhyay’s research and academic work are well-regarded, with his contributions earning recognition through numerous awards and honors. Notable accolades include the American College of Radiation Oncology (ACRO) Best Abstract Award and the American Radium Society (ARS) Early Career Oncologist Award, which are testaments to his influential research on topics like stereotactic radiosurgery and palliative radiation therapy. These accolades further cement his reputation in the academic community, demonstrating the high regard in which his peers hold his research.

Technical Skills 💻

Dr. Upadhyay has developed a comprehensive set of technical skills that position him at the cutting edge of radiation oncology. His expertise spans advanced radiation therapy techniques such as stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), proton therapy, and image-guided brachytherapy. In addition, he is well-versed in cutting-edge technologies, including the use of artificial intelligence and machine learning in radiation oncology for treatment planning and quality assurance. His technical acumen is further demonstrated by his involvement in developing new approaches to enhance clinical outcomes for complex cancer cases.

Teaching Experience 📖

Dr. Upadhyay has dedicated substantial time to teaching and mentorship, sharing his expertise with medical students, residents, and fellow researchers. He has served as a moderator for educational webinars and a mentor for various research initiatives. His roles as a panelist and speaker at international conferences, such as the ASTRO Annual Meeting and the Ohio State University Cardio-Oncology Symposium, reflect his commitment to advancing education within the field of oncology. Through these initiatives, he has played a key role in shaping the future of radiation oncology education.

Legacy and Future Contributions 🔮

Dr. Upadhyay’s legacy in radiation oncology is already being established through his groundbreaking research and mentorship. His involvement in international clinical trials, such as the AVATAR system and the PRIMe-STAR trial, is likely to make a long-lasting impact on the clinical management of cancer patients globally. Looking forward, Dr. Upadhyay plans to continue advancing his research, particularly in the areas of stereotactic radiosurgery and precision medicine. His work promises to significantly shape the future of radiation oncology, particularly in improving treatment efficacy, minimizing side effects, and enhancing patient care across diverse populations.

 

Top Noted Publications 📖

Additive Value of Magnetic Resonance Simulation Before Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas

Authors: Divya Yadav, Rituraj Upadhyay, Vinodh A. Kumar, Melissa M. Chen, Jason M. Johnson, Holly Langshaw, Brandon J. Curl, Maguy Farhat, Wasif Talpur, Thomas H. Beckham et al.

Journal: Practical Radiation Oncology

Year: 2024

Risk-Stratified Radiotherapy in Pediatric Cancer

Authors: Rituraj Upadhyay, Arnold C. Paulino

Journal: Cancers

Year: 2024

Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients

Authors: Rituraj Upadhyay, Brett Klamer, Jennifer Matsui, Vikram B. Chakravarthy, Thomas Scharschmidt, Nicholas Yeager, Bhuvana A. Setty, Timothy P. Cripe, Ryan D. Roberts, Jennifer H. Aldrink et al.

Journal: Cancers

Year: 2024

Quantifying the Risk and Dosimetric Variables of Symptomatic Brainstem Injury after Proton Beam Radiation in Pediatric Brain Tumors

Authors: Rituraj Upadhyay, Kaiping Liao, David R Grosshans, Susan L McGovern, Mary Frances McAleer, Wafik Zaky, Murali M Chintagumpala, Anita Mahajan, Debra Nana Yeboa, Arnold C Paulino

Journal: Neuro-Oncology

Year: 2022

Patterns of Failure after Radiation Therapy in Primary Spinal High-Grade Gliomas: A Single Institutional Analysis

Authors: Rituraj Upadhyay, Swapnil Khose, Halyna Pokhylevych, Arnold C Paulino, Mary Frances McAleer, Amol Ghia, Jing Li, Debra Nana Yeboa, Monica Loghin, Rebecca Harrison et al.

Journal: Neuro-Oncology Advances

Year: 2022

Christopher Prashad | Public Health | Best Researcher Award

Posted on by ScienceFather

Dr. Christopher Prashad | Public Health | Best Researcher Award

York University, Canada

Author Profile 📚

Orcid

🔍 Summary

Dr. Christopher Prashad is a PhD candidate in Mathematics and Statistics, specializing in Data Science for Public Health at York University. With a strong foundation in advanced quantitative research, including time series analysis, machine learning, stochastic simulation, and probabilistic programming, Dr. Prashad excels in transforming complex data into actionable insights. He has a proven track record of collaborating with academic and industry teams, effectively communicating technical concepts, and is eager to apply his skills in Data Science to drive meaningful decision-making.

🎓 Education

Dr. Prashad is currently pursuing his PhD in Mathematics and Statistics – Data Science for Public Health at York University (expected June 2025). He is also completing a MicroMasters in Finance from MIT Sloan School of Management (expected January 2025). He holds a Master’s degree in Mathematics and Statistics from York University and a Bachelor of Science in Mathematics and Chemistry from the University of Toronto.

💼 Professional Experience

Dr. Prashad has worked as a Mathematics for Public Health Researcher at York University–Sanofi Pasteur (2022–2024), where he collaborated with pharmaceutical companies and public health organizations to drive evidence-based policies and modeling initiatives. Prior to this, he worked as a Statistician at Western University (2014–2019), conducting longitudinal studies to assess the impact of STEM education programs. He has also served as a Course Director for Statistical Methods in Health Studies at York University (2018–2019), delivering lectures and tutorials while fostering student engagement in applied statistics.

📚 Academic Projects & Presentations

Dr. Prashad has contributed to several notable academic projects, such as Multiperiod Forecasting of Epidemic Prevalence using machine learning to predict the spread of flu-like illnesses, and Stochastic Threshold Analysis for SIRS Model, where he applied advanced mathematical techniques to epidemic modeling. He also analyzed Indexed GIC Investment Products using stochastic volatility models, presenting his findings to industry leaders in finance.

💻 Technical Skills

Dr. Prashad is proficient in a wide range of software and analytical tools, including Python, R, MATLAB, SQL, SPSS, and C. He specializes in Time Series Analysis, Stochastic Simulation, Machine Learning, Multivariate Statistics, and Probabilistic Programming, with expertise in Bayesian Methods, Optimization, and Data Visualization.

👩‍🏫 Teaching Experience

As a Course Director at York University, Dr. Prashad designed and delivered lectures on statistical methods in health studies, supported diverse student learning needs, and contributed to collaborative course design and student development.

🔬 Research Interests

Dr. Prashad’s research interests lie at the intersection of data-driven public health modeling, machine learning in healthcare, and mathematical epidemiology, with a particular focus on applying quantitative analysis to solve public health challenges.

 

📖 Top Noted Publications

Stochastic Threshold Analysis for Mean-Reverting SIRS Model
    • Authors: Dr. Christopher Prashad (and collaborators)
    • Journal: Journal of Theoretical Biology
    • Year: 2024
Problems and Solutions in Modern Finance, Financial Accounting, Mathematical Methods for Quantitative Finance, and Derivatives Markets
    • Authors: Dr. Christopher Prashad (and collaborators)
    • Journal: Independent publication
    • Year: 2024
Assessing the Impact of Community Mobility on COVID-19 Dynamics
    • Authors: Dr. Christopher Prashad (and collaborators)
    • Journal: PLOS Computational Biology
    • Year: 2024
State-Space Modelling for Infectious Disease Surveillance Data: Stochastic Simulation Techniques and Structural Change Detection
    • Authors: Dr. Christopher Prashad (and collaborators)
    • Journal: Journal of Infectious Disease Modelling, Primer Articles
    • Year: 2024
State-Space Modelling for Infectious Disease Surveillance Data: Dynamic Regression and Covariance Analysis
    • Authors: Dr. Christopher Prashad (and collaborators)
    • Journal: Journal of Infectious Disease Modelling, Primer Articles
    • Year: 2024

Tahar Kernif | Healthcare Data Analysis | Excellence in Research

Posted on by ScienceFather

Dr. Tahar Kernif | Healthcare Data Analysis | Excellence in Research

Institut Pasteur Algérie, Algeria

Author Profile

🎓 Early Academic Pursuits

Dr. Tahar Kernif’s academic journey began in 2004 when he completed his Doctorate in Veterinary Science at the École Nationale Vétérinaire d’Alger, where he conducted a comparative study on treatments for canine Leishmaniasis. This research laid the foundation for his future work in veterinary parasitology. Dr. Kernif then pursued a Magistère in Parasitology at the same institution, focusing on zoonotic diseases and vectors, which further honed his expertise in vector-borne infections. These early academic achievements earned him distinction and sparked his lifelong commitment to studying infectious diseases.

🧑‍🔬 Professional Endeavors

Since 2013, Dr. Kernif has been a Maître de Recherche at the Institut Pasteur d’Alger, where he works on molecular techniques to study parasitic diseases in veterinary science. His research focuses on Protozoa, Helminths, and the molecular ecology of arthropod vectors. He has played an integral role in shaping the institute’s research activities on infectious diseases and environmental health, contributing to key initiatives in the field of veterinary parasitology. Dr. Kernif’s professional work is also marked by collaborations with international research institutions such as CIRAD and IRD, where he has worked on studying arthropod microbiota through meta-proteomics.

🔬 Contributions and Research Focus

Dr. Kernif’s primary research interests lie in Infectious Diseases and Health and Environment, specifically focusing on multi-omics approaches to understanding pathogen behavior. His work spans genomics, metagenomics, and proteomics, applying these techniques to study diseases like leishmaniasis and tick-borne infections. His research includes phylogenetic analysis and bioinformatic modeling, which have contributed significantly to the molecular understanding of parasite-host interactions, providing insights into disease transmission and control strategies.

🌍 Impact and Influence

Dr. Kernif’s contributions extend beyond research, as he is actively involved in national health policy and scientific review boards. He served as associate editor for New Microbes and New Infections and has been a scientific examiner for the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). His work has shaped policies related to biodiversity and environmental health, especially in Algeria, where he is part of the National Expert Working Group for the Libreville Declaration on Health and Environment. His influence on public health and policy is a testament to his broad impact in both scientific and governmental circles.

📚 Academic Cites

Dr. Kernif has authored 35 international publications and contributed to two book chapters, demonstrating his prominent role in infectious disease research. His studies are frequently cited in scientific journals, reflecting his influence in veterinary parasitology and zoonotic diseases. His work in molecular epidemiology and vector-borne pathogens has made a lasting impact on the field and continues to guide contemporary research.

🛠️ Technical Skills

Dr. Kernif is highly proficient in a range of advanced techniques critical to research in parasitology and microbiology. His expertise spans capillary sequencing, next-generation sequencing (NGS), and PCR/qPCR, which are essential for molecular surveillance and unraveling genetic information. He is also skilled in MALDI-TOF Mass Spectrometry, currently in progress, allowing for detailed molecular analysis of pathogens. Additionally, Dr. Kernif utilizes bioinformatics to analyze complex datasets, helping to interpret vast amounts of biological data. His proficiency in meta-proteomics is instrumental in studying the microbiota of arthropods, providing insights into disease mechanisms and transmission. These tools equip Dr. Kernif with the ability to conduct precise and impactful research, advancing our understanding of infectious diseases.

👩‍🏫 Teaching Experience

Throughout his career, Dr. Kernif has shared his expertise through academic mentorship and scientific training. As a researcher at the Institut Pasteur d’Alger, he supervises graduate students and engages in international collaborations to promote knowledge exchange. His teaching and mentorship in the field of veterinary parasitology and infectious diseases continue to shape the next generation of scientists.

🌱 Legacy and Future Contributions

Dr. Kernif’s legacy is marked by his scientific publications, international collaborations, and his influence in shaping research policy in infectious diseases. Moving forward, his research is poised to address emerging health threats, particularly those arising from vector-borne diseases. His continued contributions to global health initiatives and his work on disease surveillance are expected to leave a lasting mark on the fields of veterinary entomology and infectious disease control.

 

📖 Top Noted Publications

Update on tick-borne rickettsioses around the world: a geographic approach
    • Authors: P Parola, CD Paddock, C Socolovschi, MB Labruna, O Medianikov, …
    • Journal: Clinical Microbiology Reviews
    • Year: 2013
Borrelia, Rickettsia, and Ehrlichia species in bat ticks, France, 2010
    • Authors: C Socolovschi, T Kernif, D Raoult, P Parola
    • Journal: Emerging Infectious Diseases
    • Year: 2012
Matrix-assisted laser desorption ionization–time of flight mass spectrometry for rapid identification of tick vectors
    • Authors: A Yssouf, C Flaudrops, R Drali, T Kernif, C Socolovschi, JM Berenger, …
    • Journal: Journal of Clinical Microbiology
    • Year: 2013
Identification of flea species using MALDI-TOF/MS
    • Authors: A Yssouf, C Socolovschi, H Leulmi, T Kernif, I Bitam, G Audoly, L Almeras, …
    • Journal: Comparative Immunology, Microbiology and Infectious Diseases
    • Year: 2014
Rickettsiae of spotted fever group, Borrelia valaisiana, and Coxiella burnetii in ticks on passerine birds and mammals from the Camargue in the south of France
    • Authors: C Socolovschi, P Reynaud, T Kernif, D Raoult, P Parola
    • Journal: Ticks and Tick-Borne Diseases
    • Year: 2012

Chitchamai Ovatlarnporn | Drug development | Best Researcher Award

Posted on by ScienceFather

Assist Prof Dr. Chitchamai Ovatlarnporn | Drug development | Best Researcher Award

Assist Prof Dr. Chitchamai Ovatlarnporn at Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hatyai, Songkhla, Thailand

👨‍🎓Professional Profiles

🧑‍🏫 Early Academic Pursuits

Dr. Chitchamai Ovatlarnporn’s academic journey began with a solid foundation in pharmacy. She earned her Bachelor of Pharmacy (Second Honours) from Songkhla University in 1990. Building on this, she went on to pursue higher education internationally, receiving a Master’s Degree in Biotechnology from the University of Kent at Canterbury in 1993, and later obtaining a Ph.D. in Chemistry from the University of Ottawa in 2000. This educational progression laid the groundwork for her distinguished career in pharmaceutical sciences, particularly in the areas of drug delivery systems, medicinal chemistry, and biotechnology.

💼 Professional Endeavors

Dr. Ovatlarnporn’s professional career has been deeply intertwined with both academic and research excellence. She holds a prominent position as an Associate Professor at the Faculty of Pharmaceutical Sciences, Prince of Songkla University (PSU), Thailand. In addition to her teaching responsibilities, she is a pivotal figure in the Department of Pharmaceutical Chemistry at PSU, where she focuses on cutting-edge pharmaceutical research, particularly related to drug development and delivery systems. Over the years, she has successfully combined her roles as an educator, researcher, and consultant in various national and international research projects.

Her expertise extends to consulting for product development and research with projects like Move World Together and Tech2BiZ, reflecting her dynamic role in fostering innovation within the pharmaceutical and biotechnology industries.

🔬 Contributions and Research Focus

Dr. Ovatlarnporn’s research is diverse and far-reaching, focusing primarily on drug delivery systems, pharmaceutical chemistry, and biotechnology. One of her major research interests lies in the development of nanotechnology-based drug delivery systems, such as the preparation and evaluation of nanomicelles for enhanced solubility and bioavailability of poorly water-soluble drugs like curcumin and resveratrol.

She has also made significant contributions to pharmacological research, investigating the antioxidant, anti-inflammatory, and anticancer properties of various medicinal plants and their bioactive compounds. Her work also includes genetic engineering, the synthesis of novel compounds, and the utilization of biopolymers for targeted drug delivery systems, particularly in colon-specific drug delivery.

🌍 Impact and Influence

Dr. Ovatlarnporn’s work has had a significant impact on both the academic and pharmaceutical industries. Her research on tetrhydrocurcumins, curcumin derivatives, and chitosan-based drug delivery systems has opened new avenues for cancer therapy, chronic disease management, and sustainable biopharmaceutical innovations.

Her published works are frequently cited in high-impact journals such as Food Bioscience, Journal of Drug Delivery Science and Technology, and Molecules, making her an influential researcher in her field. Her studies on natural compounds such as Viola stocksii and Tiliacora triandra have advanced the scientific understanding of their pharmacological potentials, contributing to the growing body of knowledge in natural product-based drug development.

📚 Academic Cites & Recognition

Dr. Ovatlarnporn has authored and co-authored numerous peer-reviewed papers, making significant contributions to the fields of medicinal chemistry, pharmaceutical biotechnology, and drug delivery systems. Notable publications include:

  • “Evaluation of the Anti-Inflammatory, Antioxidant, and Cytotoxic Potential of Cardamine Amara L.” published in Frontiers in Chemistry (Impact Factor: 5.5).
  • “Insights into the remarkable attenuation of hen egg white lysozyme amyloid fibril formation mediated by biogenic gold nanoparticles” in the International Journal of Biological Macromolecules (Impact Factor: 8.2).
  • Research on Acanthus ebracteatus and its bioactive properties, published in Molecules.

Her work is widely recognized, with her publications frequently cited by fellow researchers and practitioners in the pharmaceutical sciences, demonstrating her high standing in the global research community.

🛠 Technical Skills

Dr. Ovatlarnporn is proficient in a wide range of technical skills essential to her research work. These include:

  • Nanotechnology and Drug Delivery Systems: Expertise in the preparation and evaluation of drug formulations, particularly nanomicelles and nanoemulsions.
  • Medicinal Chemistry: Deep knowledge of bioactive natural products, their chemical properties, and potential therapeutic applications.
  • Pharmacological Research: Extensive experience in designing and conducting in vitro and in vivo studies to assess the biological activity of plant-based compounds.
  • Analytical Techniques: Skilled in HPLC, GC-MS, NMR, and spectroscopic methods for the identification and quantification of bioactive compounds.
  • Molecular Docking & Computational Studies: Proficient in using in silico models for studying molecular interactions and optimizing drug efficacy.

👨‍🏫 Teaching Experience

As an academic leader at Prince of Songkla University, Dr. Ovatlarnporn has had a profound influence on shaping the next generation of pharmaceutical scientists. Her teaching areas cover various aspects of medicinal chemistry, drug delivery systems, biotechnology, and pharmaceutical technology. She is known for integrating cutting-edge research findings into her curriculum, ensuring that students are exposed to the latest advancements in the field. Her mentoring has inspired numerous graduate students, many of whom have gone on to achieve their own academic and professional successes.

🌱 Legacy and Future Contributions

Looking forward, Dr. Ovatlarnporn is committed to advancing research on nanotechnology and its applications in targeted drug delivery systems. She aims to further her work on sustainable biopharmaceutical innovations and natural product-based therapies, especially in cancer treatment and chronic disease management. Her research in collaboration with industry partners promises to continue to bridge the gap between academic research and commercial product development, ensuring that her contributions have lasting real-world impact.

In the future, Dr. Ovatlarnporn plans to focus on enhancing the bioavailability of natural bioactive compounds, developing more efficient drug delivery platforms, and promoting interdisciplinary collaborations within the fields of pharmacy, biotechnology, and medicine. Her continued dedication to research excellence and academic mentorship ensures her legacy will live on in both the scientific community and the generations of students she has mentored.